FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

735135008: Aspirin DL-lysine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3513231010 Aspirin DL-lysine (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
3513232015 Acetylsalicylate DL-lysine en Synonym Active Only initial character case insensitive SNOMED CT core module
3513233013 Aspirin DL-lysine en Synonym Active Only initial character case insensitive SNOMED CT core module
106967901000001116 Aspirin DL-Lysine en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aspirin DL-lysine Is a Lysine false Inferred relationship Existential restriction modifier
Aspirin DL-lysine Is a Aspirin false Inferred relationship Existential restriction modifier
Aspirin DL-lysine Is modification of Aspirin true Inferred relationship Existential restriction modifier
Aspirin DL-lysine Is a Salicylate true Inferred relationship Existential restriction modifier
Aspirin DL-lysine Is a Antiplatelet agent false Inferred relationship Existential restriction modifier
Aspirin DL-lysine Has disposition Platelet aggregation inhibitor true Inferred relationship Existential restriction modifier
Aspirin DL-lysine Is a Non-steroidal anti-inflammatory agent true Inferred relationship Existential restriction modifier
Aspirin DL-lysine Is a Substance with platelet aggregation inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder Has precise active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder Has basis of strength substance True Aspirin DL-lysine Inferred relationship Existential restriction modifier 2
Aspirin 1g powder and solvent for solution for injection vials 20 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspegic Injectable 1g powder and solvent for solution for injection vials (sanofi-aventis) 6 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspirin 1g powder and solvent for solution for injection vials Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspegic Injectable 1g powder and solvent for solution for injection vials (sanofi-aventis) 20 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspegic Injectable 1g powder and solvent for solution for injection vials (sanofi-aventis) Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspirin 1g powder and solvent for solution for injection vials 6 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspirin 500mg powder and solvent for solution for injection vials Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspegic Injectable 500mg powder and solvent for solution for injection vials (sanofi-aventis) 6 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspegic Injectable 500mg powder and solvent for solution for injection vials (sanofi-aventis) 20 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspegic Injectable 500mg powder and solvent for solution for injection vials (sanofi-aventis) Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspirin 500mg powder and solvent for solution for injection vials 6 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspirin 500mg powder and solvent for solution for injection vials 20 vial Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
MigraMax oral powder sachets (Zentiva Pharma UK Ltd) 20 sachet Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspirin 900mg / Metoclopramide 10mg oral powder sachets sugar free 6 sachet Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
MigraMax oral powder sachets (Zentiva Pharma UK Ltd) 6 sachet Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
Aspirin 900mg / Metoclopramide 10mg oral powder sachets sugar free 20 sachet Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier
MigraMax oral powder sachets (Zentiva Pharma UK Ltd) Has specific active ingredient True Aspirin DL-lysine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start